Shares of Credo Technology Group Holding Ltd (NASDAQ:CRDO) rose sharply in today's pre-market trading following upbeat quarterly results.
The company reported fourth-quarter revenue of $170.03 million, beating analyst estimates of $162.96 million. The connectivity solutions company reported fourth-quarter adjusted earnings of 35 cents per share, beating analyst estimates of 28 cents per share, according to Benzinga Pro.
Credo Technology Group shares jumped 14.3% to $71.60 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- NewGenIvf Group Limited (NASDAQ:NIVF) shares jumped 192.4% to $5.03 in pre-market trading. NewGenIvf Group recently announced a $30 million investment in Solana Digital Asset staking.
- Shineco, Inc. (NASDAQ:SISI) surged 36.4% to $0.5878 in pre-market trading after the company announced that it will raised $13.5 million through the sale of 18 million common shares at $0.75 each to non-US investors.
- Revelation Biosciences, Inc. (NASDAQ:REVB) rose 36.2% to $1.12 in pre-market trading. Revelation Biosciences recently announced a $4 million public offering.
- Eyenovia, Inc. (NASDAQ:EYEN) jumped 31.4% to $2.19 in pre-market trading. Eyenovia recently provided an update on its merger with Betaliq and reported better-than-expected first-quarter EPS results.
- Northern Dynasty Minerals Ltd. (NYSE:NAK) surged 25.2% to $1.44 in pre-market trading. Northern Dynasty Minerals received payment of $12 million representing the third tranche investment under the company's royalty agreement dated July 26, 2022.
- Basel Medical Group Ltd (NASDAQ:BMGL) gained 24% to $4.86 in pre-market trading after falling 35% on Monday.
- MoonLake Immunotherapeutics (NASDAQ:MLTX) climbed 21.1% to $49.84 in pre-market trading following reports that Merck held talks to acquire the Swiss biotech company for over $3 billion.
- Agenus Inc. (NASDAQ:AGEN) rose 18.4% to $4.89 in pre-market trading after jumping 20% on Monday.
- BioNTech SE (NASDAQ:BNTX) gained 8.4% to $122.62 in pre-market trading. BioNTech shares jumped 18% on Monday after the company entered into an agreement with Bristol Myers Squibb to advance bispecific antibody BNT327 for solid tumors.
Losers
- Brand Engagement Network, Inc. (NASDAQ:BNAI) shares dipped 16% to $0.4119 in pre-market trading after jumping over 75% on Monday.
- CleanCore Solutions, Inc. (NYSE:ZONE) shares fell 17.6% to $2.39 in pre-market trading after gaining around 32% on Monday.
- PS International Group Ltd. (NASDAQ:PSIG) fell 16.7% to $0.30 in pre-market trading.
- ModivCare Inc. (NASDAQ:MODV) fell 15% to $1.87 in pre-market trading after jumping 96% on Monday.
- AgEagle Aerial Systems, Inc. (NYSE:UAVS) shares tumbled 14.3% to $1.08 in pre-market trading after jumping 63% on Monday.
- Volato Group, Inc. (NYSE:SOAR) declined 14.2% to $2.25 in pre-market trading after gaining 27% on Monday.
- Mereo BioPharma Group plc (NASDAQ:MREO) fell 5.9% to $2.40 in pre-market trading after jumping over 18% on Monday.
- Bumble Inc. (NYSE:BMBL) fell 5.8% to $5.41 in today's pre-market trading.
- Pearson plc (NYSE:PSO) dipped 5% to $15.24 in pre-market trading.
- GCL Global Holdings Ltd (NASDAQ:GCL) shares fell 4.8% to $2.40 in pre-market trading.
Now Read This:
Photo via Shutterstock